A Fluorescence-based Optomechanical Sensor for Intraocular Pressure Monitoring

用于眼压监测的基于荧光的光机械传感器

• 批准号: 8224924
• 负责人: Nikolaos Chronis
• 金额: $ 18.3万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8224924
• 关键词: Aqueous Humor; Architecture; Bathing; Blood Pressure; Chronic; Clinic; Clinic Visits; Clinical Trials; Detection; Development; Devices; Diagnosis; Diagnostic; Disease; Disease Progression; Electronics; Eye; Family member; Fluorescence; Glass; Glaucoma; Goals; Gold; Head; Home environment; Hospitals; Human Resources; Humor; Hypertension; Implant; In Vitro; Intracranial Pressure; Intraocular lens implant device; Iris; Life; Light; Maintenance; Measurement; Membrane; Microfabrication; Monitor; Nerve; Ocular Hypertension; Optics; Output; Patient Monitoring; Patients; Physiologic Intraocular Pressure; Process; Quantum Dots; Research; Signal Transduction; Silicon; Surface; System; Taxes; Technology; Time; Tissues; Training; Treatment Efficacy; Variant; Visit; Visual Fields; Work; absorption; aqueous; base; design; flexibility; gastrointestinal pressure; in vitro testing; light intensity; light weight; miniaturize; novel; optical sensor; point of care; pressure; sensor; tonometry; tool

DESCRIPTION (provided by applicant): IntraOcular Pressure (IOP) monitoring is an essential diagnostic tool for the efficient treatment of glaucoma and other ocular hypertension-related diseases. Clinical trials have shown that frequent IOP monitoring can decelerate the progress of glaucoma and minimize optical nerve damage Current IOP monitoring technologies (e.g. tonometry) are non-invasive and simple to execute, but they are not accurate and not suitable for life-long and frequent IOP monitoring: they require a visit to the hospital or to a clinic as the measurement is performed by trained personnel. We propose a 'Near Infrared Fluorescent-based Optomechanical' (NiFO) IOP sensing technology for accurate, home-based, IOP monitoring for patients with moderate or severe glaucoma. The NiFO technology is based on an electronic-free MicroElectroMechanical Systems (MEMS) implantable sensor (termed the 'NiFO sensor') that converts IOP changes into a dual-wavelength optical signal in the near infrared (NI) regime. The NiFO sensor is integrated into an intraocular lens or surgically attached on the iris and therefore permanently implanted into the patient's eye. An external, portable optical readout system (ORS) is used to excite the NiFO sensor, collect and analyze the emitted NI optical signal. The power-free NiFO sensor permits frequent and life-long IOP monitoring, allows the patient to perform the IOP measurement at home, requires no maintenance (e.g. battery replacement), it is accurate and it has a very small size (< 0.5 mm3) and footprint (~0.25 mm2). Our research plan consists of the following aims: 1) Microfabrication and in vitro testing of the NiFO pressure sensor. The NiFO sensor, consisting of a silicon/PDMS chip will be microfabricated using standard bulk and surface silicon micromachining processes. Its specifications (dynamic range, precision error, etc) will be established in vitro by immersing the NIFO sensor into a bath filled with aqueous humor. 2) Construction of the Optical Readout System (ORS). A portable optical readout system consisting of an optical head and an excitation/detection unit will be manufactured. The system will integrate all the optics needed to excite the NiFO sensor, collect analyze the emitted NI fluorescence signal. The proposed technology will help in efficiently managing and treating glaucoma and hypertension-related diseases and it will trigger the development of other implantable, power-free, miniaturized devices that can be used in a variety of pressure monitoring biomedical applications. PUBLIC HEALTH RELEVANCE: Intraocular pressure (IOP) monitoring is an important diagnostic tool for accessing the pathological condition of patients with chronic glaucoma. This work aims to develop a new class of point-of-care, implantable IOP monitoring sensors that will provide better management and efficient treatment for such patients.

描述（由申请人提供）：眼内压（IOP）监测是有效治疗青光眼和其他高眼压相关疾病的重要诊断工具。临床试验表明，频繁的IOP监测可以减缓青光眼的进展，并最大限度地减少视神经损伤。目前的IOP监测技术（例如眼压计）是无创的，执行简单，但它们不准确，不适合终身和频繁的IOP监测：它们需要访问医院或诊所，因为测量是由训练有素的人员进行的。我们提出了一种“近红外线折射率为基础的光学机械”（NiFO）IOP传感技术，用于准确的，家庭为基础的，中度或重度青光眼患者的IOP监测。NiFO技术基于无电子微机电系统（MEMS）植入式传感器（称为“NiFO传感器”），该传感器将IOP变化转换为近红外（NI）范围内的双波长光信号。NiFO传感器被集成到眼内透镜中或通过手术连接到虹膜上，因此被永久植入患者的眼睛中。外部便携式光学读出系统（ORS）用于激励NiFO传感器，收集和分析发射的NI光信号。免电源NiFO传感器允许频繁和终身的IOP监测，允许患者在家中进行IOP测量，无需维护（例如更换电池），它是准确的，并且具有非常小的尺寸（< 0.5 mm 3）和占地面积（~0.25 mm 2）。我们的研究计划包括以下目标：1）NiFO压力传感器的微加工和体外测试。NiFO传感器由硅/PDMS芯片组成，将使用标准的体硅和表面硅微加工工艺进行微加工。将通过将NIFO传感器浸入充满房水的水浴中，在体外确定其质量标准（动态范围、精度误差等）。2)光学读出系统（ORS）的构造。将制造一个便携式光学读出系统，包括一个光学头和一个激发/检测单元。该系统将集成激发NiFO传感器所需的所有光学器件，收集分析发射的NI荧光信号。这项技术将有助于有效地管理和治疗青光眼和高血压相关疾病，并将引发其他可植入、无电源、小型化设备的开发，这些设备可用于各种压力监测生物医学应用。 公共卫生相关性：眼内压（IOP）监测是评估慢性青光眼患者病理状态的重要诊断工具。这项工作的目的是开发一种新的护理点，植入式IOP监测传感器，将为这些患者提供更好的管理和有效的治疗。